CP17640152376531430 — Pembrolizumab 25 Mg/ml4 Ml Sdv [Chas]
$7,113
All-payer median here
$9,484
Cash / self-pay here
4
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.